NEVVI Medicare utilization intelligence
or

← back

Provider profile

HERRMANN, JAMES MD

Dermatology · NPI 1407822216 · WHEATON, IL

1
Groups
29
Codes · 2024
2,923
Disclosed services

HERRMANN, JAMES is a Dermatology in WHEATON, IL, a member of 1 medical group, who billed 29 distinct codes to Medicare Part B in 2024.

Groups: DUPAGE MEDICAL GROUP LTD (GLEN ELLYN, IL)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

2,923
disclosed services
29
codes billed to Medicare Part B
Prior year · CY2023 3,718 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths
88305 Pathology examination of tissue using a microscope, intermediate complexity
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
17000 Destruction of precancer skin growth, 1 growth
17110 Destruction of skin growth, 1-14 growths
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
96567 Application of light to destroy precancer skin growth
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm
11602 Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm
11311 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
11302 Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm
88304 Pathology examination of tissue using a microscope, moderately low complexity
11310 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
11622 Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
11603 Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm
36415 Insertion of needle into vein for collection of blood sample
12042 Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm
17004 Destruction of precancer skin growth, 15 or more growths
96372 Injection of drug or substance under skin or into muscle
11306 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
11102 Biopsy of related skin growth, first growth
11402 Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm
12052 Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm
11300 Shaving of skin growth of body, arms, or legs, 0.5 cm or less

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.